Edema
📧 Sign up to get email alerts when something new happens for Edema.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-04-19FDA Approved: THALITONE — Supplemental Application (Casper Pharma LLC)
FDA approved a supplemental application for THALITONE (chlorthalidone) submitted by Casper Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2018-03-27Clinical Trial Update: Relation Between the Increase of Peripheral Edema by Fluid Therapy and the Decrease in Microcirculatory Vesseldensity
A clinical trial update examining the relationship between fluid-therapy–associated peripheral edema and decreased microcirculatory vessel d…
-
CLINICAL_TRIALS trial_result · 2017-11-14Clinical Trial Update: Oedematous Lower Limb Subcutaneous Drainage in Palliative Care [NA]
This terminated clinical trial (NCT02473744) from University Hospital, Limoges, studied oedematous lower limb subcutaneous drainage in palli…
-
FDA approval · 2017-09-22FDA Approved: INDAPAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Indapamide (ANI Pharmaceuticals), updating its regulatory approval.
-
FDA approval · 2017-07-14FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc. The notice confirms regulatory approval o…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-31Clinical Trial Update: Impact of Preemptive Intravenous Ibuprofen on Postoperative Edema and Trismus in the Third Molar Teeth [NA]
A clinical trial is evaluating whether preemptive intravenous ibuprofen reduces postoperative edema and trismus after third molar (wisdom to…
-
FDA approval · 2017-03-30FDA Approved: CHLORTHALIDONE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved an original application for chlorthalidone from Rising Pharma Holdings, Inc., a generic diuretic indicated for hypertension and…
-
FDA approval · 2017-01-26FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for hydrochlorothiazide filed by Actavis Pharma, Inc. to update the product labeling.
-
FDA approval · 2016-10-27FDA Approved: ACETAZOLAMIDE — Original Application (Chartwell RX, LLC)
FDA approved an original application for acetazolamide from Chartwell RX, LLC.
-
FDA approval · 2016-09-22FDA Approved: FUROSEMIDE — Supplemental Application (Hospira, Inc.)
FDA approves Hospira, Inc.'s supplemental application for furosemide, initiating a supplemental approval for the drug. The action updates th…
-
FDA approval · 2016-09-19FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)
FDA approved a supplemental application for furosemide submitted by Phlow Corporation.
-
FDA approval · 2016-09-19FDA Approved: SPIRONOLACTONE — Original Application (Accord Healthcare, Inc.)
FDA approves Accord Healthcare, Inc.'s original application for spironolactone (generic), authorizing its use as a potassium-sparing diureti…
-
FDA approval · 2016-07-20FDA Approved: FUROSEMIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's original application for furosemide, authorizing a generic version of this diuretic.
-
FDA approval · 2016-06-30FDA Approved: ETHACRYNIC ACID — Original Application (Edenbridge Pharmaceuticals LLC.)
The FDA approved Edenbridge Pharmaceuticals' original application for Ethacrynic acid, a loop diuretic used to treat edema associated with h…
-
CLINICAL_TRIALS trial_result · 2016-06-22Clinical Trial Update: Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes [NA]
A completed clinical trial evaluated a mild compression sock to control lower-extremity edema in individuals with diabetes; results were pos…
-
FDA approval · 2016-06-14FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of spironolactone and hydrochlorothiazide from Mylan Pharma…
-
CLINICAL_TRIALS research · 2016-05-11Clinical Trial Update: Low Laser Light Therapy After Impacted Third Molar Removal [NA]
A University of Sao Paulo trial is evaluating low laser light therapy to reduce trismus, edema, and pain after impacted third molar removal;…
-
CLINICAL_TRIALS trial_result · 2016-03-09Clinical Trial Update: Optimization of Onpulse Technology for Patients With Post Surgical or Vascular Oedema [EARLY_Phase 1]
This early-phase 1 trial update reports completion of a study evaluating Onpulse Technology for patients with edema (post-surgical or vascul…
-
FDA approval · 2016-03-08FDA Approved: FUROSEMIDE — Supplemental Application (Phlow Corporation)
FDA approved a supplemental application for furosemide submitted by Phlow Corporation.
-
FDA approval · 2016-03-07FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for hydrochlorothiazide filed by Exelan Pharmaceuticals Inc. (ANDA).
-
FDA approval · 2016-03-04FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) submitted by Validus Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Role of Acetazolamide and Hydrochlorothiazide Followed by Furosemide in Treating Nephrotic Edema [Phase 4]
Phase 4 trial evaluating sequential diuretic therapy with acetazolamide and hydrochlorothiazide followed by furosemide for nephrotic edema. …
-
CLINICAL_TRIALS trial_result · 2016-01-12Clinical Trial Update: Microcurrent Stimulation Reduces Post-Operative Swelling and Healing Time Following Knee Replacement Surgery [NA]
A clinical trial update reports that microcurrent stimulation may reduce postoperative swelling and shorten healing time after knee replacem…
-
FDA approval · 2016-01-05FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for a generic fixed-dose combination of spironolactone and hydrochlorothiazide produced by Mylan Pha…
-
FDA approval · 2015-11-18FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (GSMS, Incorporated)
FDA approved a supplemental application for the lisinopril and hydrochlorothiazide combination from GSMS, Incorporated.